small molecule

NUEDEXTA

DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE

Loss of exclusivityAugust 2026latest FDA-listed patent expiry

CompanyOTSUKA AMERICA PHARMACEUTICAL INC

Drug detail

Brand name	NUEDEXTA
Active ingredient	DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE
Strength	20MG;10MG
Dosage form	CAPSULE
Route	ORAL
Modality	Small molecule
FDA approval	October 2010
Marketing status	RX

Listed patents

Patent	Expires	Type
7659282	August 2026	use U-1093

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.